EGFR-AS1 was found to be overexpressed in diverse cancers, including lung cancer, cervical cancer, glioma, bladder cancer, kidney cancer, head and neck cancer, gastric cancer, colorectal cancer, liver cancer, and uterine cancer. The gene discussed is EGFR; the disease is urinary bladder cancer.